Plk3, A New Player In The Hypoxia Regulatory Networ.

Plk3,缺氧调节网络的新参与者。

基本信息

  • 批准号:
    8047101
  • 负责人:
  • 金额:
    $ 33.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2015-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): HIF-1 controls the transcription of many genes that are involved in key aspects of cancer biology. Overexpression of HIF-11, an inducible subunit of HIF-1 in response to hypoxia, is a prognostic factor in many cancers. The major signaling axis mediated by PI3K, PDK1, and Akt (also referred as protein kinase B) plays a significant role in the regulation of HIF-11 expression. Both GSK32 and MAPKs are also known to directly phosphorylate HIF-11, thereby affecting its stability and/or nuclear localization. To understand the regulatory network that suppresses tumor development and tumor angiogenesis, we have recently identified HIF-11 as a new in vitro substrate of Polo-like kinase 3 (Plk3). Plk3 strongly phosphorylates HIF-11 on serines 576 and 657 in vitro, two residues that lie in the oxygen-dependent degradation domain and near the nuclear export signal, respectively. By studying primary isogenic murine embryonic fibroblasts (MEFs), we have shown that PLK3-/- MEFs are hyper-sensitive to the induction of HIF-11 under hypoxia or treated with nickel, a hypoxia mimetic. Compared with that of wild- type MEFs, PLK3-/- MEFs contain a high level of Akt1/PKB activities, which is tightly associated with the inhibitory phosphorylation of GSK32. Consistent with the potential role of Plk3 in regulating the hypoxia signaling network, PLK3-/- mice develop tumors in various organs at an advanced age and PLK3-/- tumors are large in size and highly vascularized, suggesting active tumor angiogenesis. On the basis of these observations regarding physical and functional interactions between Plk3 and HIF-11, we hypothesize that Plk3 negatively regulates the hypoxia regulatory network and HIF-11-dependent tumor angiogenesis. To test the validity of this hypothesis, we will (i) study functional interaction between Plk3 and known signaling molecules, including GSK32 and MAPKs that phosphorylate HIF-11, and identify additional Plk3 target(s) upstream of Akt1, (ii) determine whether PLK3-/- mice are prone to tumorigenesis under hypoxia, and (iii) investigate whether mice harboring Plk3 phosphorylation-resistant mutant alleles of HIF-11 are more susceptible to tumorigenesis after nickel exposure. The combined in vitro and in vivo studies will greatly facilitate the elucidation of a new mechanism by which HIF-11 is regulated by Plk3 during hypoxic responses or after exposure to environmental carcinogens such as nickel compounds. A detailed understanding of the molecular regulation of HIF-11 will add significantly to the existing knowledge of tumor angiogenesis and tumor cell resistance to anti-cancer therapies. PUBLIC HEALTH RELEVANCE: Polo-like kinases function to regulate various aspects of cell growth and cell death. Our recent biochemical and mouse genetic studies show that Plk3 plays an important role in the regulation of the HIF- 11 signaling pathway, as well as in suppressing tumorigenesis. The major goal of this project is to elucidate what signaling pathways mediate Plk3 function in hypoxic stress responses and how genotoxic metal toxicants usurp cellular mechanisms that regulate HIF-11 during hypoxia.
描述(由申请人提供):HIF-1控制癌症生物学关键方面的许多基因的转录。 HIF-11的过表达是HIF-1的诱导亚基对缺氧,是许多癌症的预后因素。由PI3K,PDK1和AKT介导的主要信号轴(也称为蛋白激酶B)在HIF-11表达的调节中起重要作用。 GSK32和MAPK也已知直接磷酸化HIF-11,从而影响其稳定性和/或核定位。为了了解抑制肿瘤发育和肿瘤血管生成的调节网络,我们最近将HIF-11确定为新的Polo样激酶3(PLK3)的新体外底物。 PLK3在体外强烈磷酸化HIF-11上的HIF-11,分别位于氧气依赖性降解域和核输出信号附近的两个残基。通过研究原发性等生鼠胚胎成纤维细胞(MEF),我们已经表明PLK3 - / - MEF对缺氧在缺氧下诱导HIF-11或用镍(镍(Mimimetic)治疗)过度敏感。与野生型MEF相比,PLK3 - / - MEF包含高水平的AKT1/PKB活性,这与GSK32的抑制性磷酸化密切相关。与PLK3在调节低氧信号网络中的潜在作用一致,PLK3 - / - 小鼠在高龄时发生了各种器官的肿瘤,PLK3 - / - 肿瘤的大小较大,并且高度血管化,表明活性肿瘤血管生成。根据这些观察结果,关于PLK3和HIF-11之间的物理和功能相互作用,我们假设PLK3负调节缺氧调节网络和HIF-111依赖性肿瘤血管生成。为了检验该假设的有效性,我们将(i)研究PLK3与已知信号分子之间的功能相互作用,包括磷酸化HIF-111的GSK32和MAPK,并确定AKT1上游的其他PLK3靶标,(ii)确定PLK3 - / - 小鼠是否在PLK3 - / - / - 小鼠中是否占据了象征性的繁殖力低下。 HIF-11的抗磷酸化 - 耐耐药性突变等位基因更容易受到镍暴露后的肿瘤发生。体外和体内研究的合并将极大地促进一种新机制的阐明,该机制在低氧反应期间或暴露于环境致癌物(如镍化合物)期间受到HIF-11的调节。对HIF-11的分子调节的详细理解将显着增加对肿瘤血管生成和抗肿瘤细胞对抗癌疗法的耐药性的知识。 公共卫生相关性:类似马球的激酶可调节细胞生长和细胞死亡的各个方面。我们最近的生化和小鼠遗传研究表明,PLK3在调节HIF-11信号通路以及抑制肿瘤发生中起着重要作用。该项目的主要目标是阐明哪种信号通路介导了低氧应激反应中的PLK3功能,以及遗传毒性金属有毒物如何篡夺在缺氧期间调节HIF-11的细胞机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

WEI DAI的其他基金

Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
  • 批准号:
    10411363
    10411363
  • 财政年份:
    2017
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
  • 批准号:
    10200691
    10200691
  • 财政年份:
    2017
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Chromatin PTEN: Its Regulation And Functions
染色质 PTEN:其调控和功能
  • 批准号:
    10689348
    10689348
  • 财政年份:
    2017
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
  • 批准号:
    8250149
    8250149
  • 财政年份:
    2012
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
  • 批准号:
    8958809
    8958809
  • 财政年份:
    2012
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
  • 批准号:
    8413001
    8413001
  • 财政年份:
    2012
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Mechanisms of arsenic-induced chromosomal instability and carcinogenesis
砷引起的染色体不稳定和致癌机制
  • 批准号:
    8572129
    8572129
  • 财政年份:
    2012
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新玩家。
  • 批准号:
    8794432
    8794432
  • 财政年份:
    2011
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新参与者。
  • 批准号:
    8403837
    8403837
  • 财政年份:
    2011
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Plk3, A New Player In The Hypoxia Regulatory Networ.
Plk3,缺氧调节网络的新参与者。
  • 批准号:
    8210839
    8210839
  • 财政年份:
    2011
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:

相似国自然基金

KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
    82200258
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
    82171845
  • 批准年份:
    2021
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
  • 批准号:
    32102530
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
什瓦赫曼-戴蒙德综合征应激反应的基因剖析
  • 批准号:
    10594366
    10594366
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Cholesterol homeostasis in the vertebrate retina
脊椎动物视网膜中的胆固醇稳态
  • 批准号:
    10580969
    10580969
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
USP27X-Cyclin D1 轴在 HER2 治疗耐药乳腺癌中的作用
  • 批准号:
    10658373
    10658373
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Upregulation of progranulin in a human iPSC-derived neurovascular model of GRN-associated Frontotemporal Dementia
GRN 相关额颞叶痴呆的人 iPSC 衍生神经血管模型中颗粒体蛋白前体的上调
  • 批准号:
    10789724
    10789724
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
    $ 33.2万
  • 项目类别: